What is the share price of MedPlus Health Services Ltd (MEDPLUS) today?
The share price of MEDPLUS as on 3rd November 2025 is ₹820.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on MedPlus Health Services Ltd (MEDPLUS) share?
The past returns of MedPlus Health Services Ltd (MEDPLUS) share are- Past 1 week: 1.36%
- Past 1 month: 2.53%
- Past 3 months: -10.40%
- Past 6 months: -1.77%
- Past 1 year: 22.33%
- Past 3 years: 38.83%
- Past 5 years: -26.86%
What are the peers or stocks similar to MedPlus Health Services Ltd (MEDPLUS)?
The peers or stocks similar to MedPlus Health Services Ltd (MEDPLUS) include:What is the market cap of MedPlus Health Services Ltd (MEDPLUS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of MedPlus Health Services Ltd (MEDPLUS) is ₹9136.48 Cr as of 3rd November 2025.What is the 52 week high and low of MedPlus Health Services Ltd (MEDPLUS) share?
The 52-week high of MedPlus Health Services Ltd (MEDPLUS) is ₹1045.30 and the 52-week low is ₹642.What is the PE and PB ratio of MedPlus Health Services Ltd (MEDPLUS) stock?
The P/E (price-to-earnings) ratio of MedPlus Health Services Ltd (MEDPLUS) is 60.78. The P/B (price-to-book) ratio is 5.25.Which sector does MedPlus Health Services Ltd (MEDPLUS) belong to?
MedPlus Health Services Ltd (MEDPLUS) belongs to the Communication Services sector & Online Services sub-sector.How to buy MedPlus Health Services Ltd (MEDPLUS) shares?
You can directly buy MedPlus Health Services Ltd (MEDPLUS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
MedPlus Health Services Ltd
MEDPLUS Share Price
820.057.50% (+57.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MEDPLUS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
MEDPLUS Performance & Key Metrics
MEDPLUS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 46.83 | 5.25 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 142.64 | 10.01 | 0.50% |
100%
Analysts have suggested that investors can buy this stock
from 6 analysts
Price Upside
Earnings Growth
Rev. Growth
MEDPLUS Company Profile
Medplus Health Services Pvt Ltd is an India-based retail pharmacy company. The Company helps customers to access its products, bills and all health records through online store, medplusmart.com, or on mobile through the MedPlus application.
ETERNAL
PE Ratio
548.61
548.61
1Y Return
31.63%
31.63%
Buy Reco %
86.67
86.67
SWIGGY
PE Ratio
-30.54
-30.54
1Y Return
11.74%
11.74%
Buy Reco %
78.26
78.26
NAUKRI
PE Ratio
92.75
92.75
1Y Return
11.97%
11.97%
Buy Reco %
77.27
77.27
PE Ratio
-126.44
-126.44
1Y Return
69.70%
69.70%
Buy Reco %
53.33
53.33
POLICYBZR
PE Ratio
232.72
232.72
1Y Return
5.58%
5.58%
Buy Reco %
61.11
61.11
MEDPLUS Sentiment Analysis
MEDPLUS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
MEDPLUS Stock Summary · August 2025
In Q1 FY'26, the company achieved consolidated revenue of Rs. 15,426 million, driven by robust pharmacy operations and a growing diagnostics segment, despite facing operational challenges such as a decline in on-time renewal rates and supply chain inefficiencies. The strategic focus on expanding its store footprint, with plans to open 600 new locations and pilot a franchise model, aims to enhance market positioning while balancing the growth of private label products against branded offerings. While recent inventory management issues have impacted operational efficiency, improvements in warehouse capacity and backend operations are expected to support future growth. Management remains cautiously optimistic about achieving profitability and enhancing margins, even as they navigate the complexities of customer retention and sales growth.
MEDPLUS Stock Growth Drivers
MEDPLUS Stock Growth Drivers
8Expansion of Store Network
MedPlus Health Services Limited has achieved significant growth in its store network, reaching a total
Operational Improvements and Infrastructure Development
The company has made substantial progress in enhancing its backend operations and infrastructure, with 6
MEDPLUS Stock Challenges
MEDPLUS Stock Challenges
6Store Closures and Operational Challenges
During the quarter, the company experienced 23 store closures, including 8 franchise conversions, resulting in
Declining Private Label Performance
There is a concern regarding a recent dip in private label share, which has negatively
MEDPLUS Forecast
MEDPLUS Forecasts
Price
Revenue
Earnings
MEDPLUS Share Price Forecast
MEDPLUS Share Price Forecast
2025
Current
₹820.05
Baseline
Forecast for Oct 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹820.05
Baseline
Forecast for Oct 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MEDPLUS Company Revenue Forecast
MEDPLUS Company Revenue Forecast
2025
Current
₹6.19
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹6.19
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
MEDPLUS Stock EPS (Earnings Per Share) Forecast
MEDPLUS Stock EPS (Earnings Per Share) Forecast
2025
Current
₹12.57
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹12.57
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
MEDPLUS
MEDPLUS
Income
Balance Sheet
Cash Flow
Annual Normal View
MEDPLUS Income Statement
MEDPLUS Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,019.55 | 2,139.00 | 2,284.94 | 2,887.88 | 3,090.82 | 3,810.64 | 4,603.66 | 5,665.61 | 6,187.70 | 6,353.81 | ||||||||||
Raw Materials | 1,617.46 | 1,734.19 | 1,872.74 | 2,583.87 | 2,530.68 | 3,141.81 | 3,778.81 | 4,582.38 | 4,634.20 | 5,744.54 | ||||||||||
| Power & Fuel Cost | 10.03 | 0.00 | 11.99 | 13.70 | 13.29 | 17.78 | 31.72 | 45.50 | 52.74 | |||||||||||
| Employee Cost | 182.19 | 189.97 | 211.37 | 272.40 | 338.65 | 393.92 | 545.13 | 625.52 | 726.02 | |||||||||||
| Selling & Administrative Expenses | 85.72 | 0.00 | 52.41 | 44.76 | 45.19 | 63.21 | 86.03 | 118.96 | 123.94 | |||||||||||
| Operating & Other expenses | 45.43 | 148.98 | 5.09 | -177.80 | -75.21 | -109.81 | -149.78 | -100.85 | 115.07 | |||||||||||
EBITDA | 78.72 | 65.86 | 131.34 | 150.95 | 238.22 | 303.73 | 311.75 | 394.10 | 535.73 | 609.27 | ||||||||||
| Depreciation/Amortization | 11.46 | 12.47 | 58.59 | 74.81 | 88.27 | 119.36 | 181.56 | 224.21 | 249.84 | 260.86 | ||||||||||
| PBIT | 67.26 | 53.39 | 72.75 | 76.14 | 149.95 | 184.37 | 130.19 | 169.89 | 285.89 | 348.41 | ||||||||||
| Interest & Other Items | 19.34 | 27.74 | 50.00 | 46.80 | 54.85 | 66.43 | 83.03 | 96.43 | 102.59 | 109.00 | ||||||||||
| PBT | 47.92 | 25.65 | 22.75 | 29.34 | 95.10 | 117.94 | 47.16 | 73.46 | 183.30 | 239.41 | ||||||||||
| Taxes & Other Items | 19.10 | -16.71 | 10.82 | 27.17 | 31.24 | 22.13 | -2.61 | 7.96 | 32.97 | 44.32 | ||||||||||
| Net Income | 28.82 | 42.36 | 11.93 | 2.17 | 63.86 | 95.81 | 49.77 | 65.50 | 150.33 | 195.09 | ||||||||||
| EPS | 761.38 | 1,039.48 | 253.29 | 42.93 | 1,325.00 | 16.00 | 4.17 | 5.48 | 12.57 | 16.30 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
MEDPLUS Company Updates
FY 2026FY 2026
Investor Presentation
Oct 31PDF
Aug 2PDF
MEDPLUS Stock Peers
MEDPLUS Past Performance & Peer Comparison
MEDPLUS Past Performance & Peer Comparison
Comparing 3 stocks from
Communication ServicesOnline Services
Compare valuation on Screener
Communication ServicesOnline Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| MedPlus Health Services Ltd | 60.78 | 5.25 | — |
| Eternal Ltd | 548.61 | 9.54 | — |
| Swiggy Ltd | -30.54 | 9.31 | — |
| Info Edge (India) Ltd | 92.75 | 2.42 | 0.44% |
MEDPLUS Stock Price Comparison
Compare MEDPLUS with any stock or ETFCompare MEDPLUS with any stock or ETF
MEDPLUS
MEDPLUS Holdings
MEDPLUS Shareholdings
MEDPLUS Promoter Holdings Trend
MEDPLUS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
High Pledged Promoter Holding
Lower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
MEDPLUS Institutional Holdings Trend
MEDPLUS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
MEDPLUS Shareholding Pattern
MEDPLUS Shareholding Pattern
MEDPLUS Shareholding History
MEDPLUS Shareholding History
Foreign Institutions
Mutual Funds Invested in MEDPLUS
Mutual Funds Invested in MEDPLUS
No mutual funds holding trends are available
Top 5 Mutual Funds holding MedPlus Health Services Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.3145% | Percentage of the fund’s portfolio invested in the stock 1.00% | Change in the portfolio weight of the stock over the last 3 months 0.49% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 40/76 (+19) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 3.0072% | Percentage of the fund’s portfolio invested in the stock 3.39% | Change in the portfolio weight of the stock over the last 3 months -0.44% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 8/40 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.9667% | Percentage of the fund’s portfolio invested in the stock 1.55% | Change in the portfolio weight of the stock over the last 3 months -0.24% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 11/87 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing MEDPLUS stock
smallcases containing MEDPLUS stock
Looks like this stock is not in any smallcase yet.
MEDPLUS Events
MEDPLUS Events
MEDPLUS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDPLUS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MEDPLUS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MEDPLUS has not given any dividends in last 5 years
MEDPLUS Dividends
MEDPLUS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeMEDPLUS Stock News & Opinions
MEDPLUS Stock News & Opinions
Articles & Videos
Spotlight
Medplus Health soars after Q2 PAT rises 43% YoY to Rs 55 cr
Profit before tax (PBT) climbed 44.3% to Rs 68.94 crore in Q2 FY26. EBITDA stood at Rs 166.3 crore in Q2 FY26, registering the growth of 22.28% compared with Rs 136 crore posted in corresponding quarter last year. EBITDA margin improved to 9.9% in Q2 FY26 as against 8.6% in Q2 FY25. On the segmental front, revenue from the retail segment rose 6.34% YoY to Rs 1,645.64 crore, while revenue from diagnostic services grew 17.45% YoY to Rs 33.25 crore in Q2 FY26. For the first half of FY26, the company's consolidated net profit surged 84.3% to Rs 97.86 crore on 5.1% increase in revenue from operations to Rs 3,221.96 crore in H1 FY26 over H1 FY25. MedPlus Health Services (MedPlus) is an organized pharmacy retail company with both an online and offline presence. The company operates in retail and wholesale sales, import, distribution, manufacturing and contract manufacturing of private-label pharmaceuticals, wellness and FMCG products and full-fledged diagnostic centers.Powered by Capital Market - Live
13 hours agoCapital Market - Live
Spotlight
Volumes jump at Medplus Health Services Ltd counter
Britannia Industries Ltd, AU Small Finance Bank Ltd, Marico Ltd, Sterling & Wilson Renewable Energy Ltd are among the other stocks to see a surge in volumes on BSE today, 03 November 2025.Medplus Health Services Ltd witnessed volume of 1.76 lakh shares by 10:46 IST on BSE, a 71.69 times surge over two-week average daily volume of 2448 shares. The stock increased 10.89% to Rs.846.00. Volumes stood at 1362 shares in the last session.Britannia Industries Ltd witnessed volume of 80348 shares by 10:46 IST on BSE, a 18.19 times surge over two-week average daily volume of 4416 shares. The stock dropped 0.25% to Rs.5,825.70. Volumes stood at 5939 shares in the last session.AU Small Finance Bank Ltd saw volume of 7.25 lakh shares by 10:46 IST on BSE, a 13.57 fold spurt over two-week average daily volume of 53444 shares. The stock dropped 0.47% to Rs.874.00. Volumes stood at 13706 shares in the last session.Marico Ltd notched up volume of 1.19 lakh shares by 10:46 IST on BSE, a 7.99 fold spurt over two-week average daily volume of 14874 shares. The stock rose 0.04% to Rs.720.65. Volumes stood at 25825 shares in the last session.Sterling & Wilson Renewable Energy Ltd registered volume of 8.85 lakh shares by 10:46 IST on BSE, a 4.73 fold spurt over two-week average daily volume of 1.87 lakh shares. The stock rose 8.98% to Rs.239.65. Volumes stood at 1.77 lakh shares in the last session.Powered by Capital Market - Live
14 hours agoCapital Market - Live
Spotlight
Medplus Health Q2 PAT rises 43% YoY to Rs 55 cr
Profit before tax (PBT) climbed 44.3% to Rs 68.94 crore in Q2 FY26. EBITDA stood at Rs 166.3 crore in Q2 FY26, registering the growth of 22.28% compared with Rs 136 crore posted in corresponding quarter last year. EBITDA margin improved to 9.9% in Q2 FY26 as against 8.6% in Q2 FY25. On the segmental front, revenue from the retail segment rose 6.34% YoY to Rs 1,645.64 crore, while revenue from diagnostic services grew 17.45% YoY to Rs 33.25 crore in Q2 FY26. For the first half of FY26, the company's consolidated net profit surged 84.3% to Rs 97.86 crore on 5.1% increase in revenue from operations to Rs 3,221.96 crore in H1 FY26 over H1 FY25. MedPlus Health Services (MedPlus) is an organized pharmacy retail company with both an online and offline presence. The company operates in retail and wholesale sales, import, distribution, manufacturing and contract manufacturing of private-label pharmaceuticals, wellness and FMCG products and full-fledged diagnostic centers. The counter advanced 0.91% to end at Rs 762.90 on the BSE.Powered by Capital Market - Live
2 days agoCapital Market - Live
Earnings
Medplus Health Services consolidated net profit rises 43.26% in the September 2025 quarter
Net profit of Medplus Health Services rose 43.26% to Rs 55.50 crore in the quarter ended September 2025 as against Rs 38.74 crore during the previous quarter ended September 2024. Sales rose 6.54% to Rs 1679.33 crore in the quarter ended September 2025 as against Rs 1576.17 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1679.331576.17 7 OPM %8.867.90 - PBDT137.50110.92 24 PBT68.9447.78 44 NP55.5038.74 43 Powered by Capital Market - Live
2 days agoCapital Market - Live
Corporate
Medplus Health Services to table results
Medplus Health Services will hold a meeting of the Board of Directors of the Company on 31 October 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Medplus Health Services to hold AGM
Medplus Health Services announced that the 19th Annual General Meeting(AGM) of the company will be held on 15 September 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
MedPlus Health Q1 PAT climbs 195% YoY to Rs 42 crore
Profit before tax (PBT) soared 196.62% YoY to Rs 52.77 crore in the quarter ended 30th June 2025. Operating EBITDA stood at Rs 72.81 crore in Q1 FY26, registering a growth of 67.53% compared to Rs 43.46 crore posted in Q1 FY25. The operating EBITDA margin improved to 4.7% in Q1 FY26, up from 2.9% in the corresponding quarter last year. On the segmental front, revenue from the retail segment rose 3.26% YoY to Rs 1,512.12 crore, while revenue from diagnostic services grew 24.95% YoY to Rs 30.29 crore in Q1 FY26. During the past 12 months, the company added 369 stores, taking the total store count to 4,813 as of 30 June 2025. MedPlus Health Services (MedPlus) is an organized pharmacy retail company with both an online and offline presence. The company operates in retail and wholesale sales, import, distribution, manufacturing and contract manufacturing of private-label pharmaceuticals, wellness and FMCG products and full-fledged diagnostic centers. The counter shed 0.26% to Rs 909.35 on the BSE. Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Medplus Health Services consolidated net profit rises 194.99% in the June 2025 quarter
Net profit of Medplus Health Services rose 194.99% to Rs 42.36 crore in the quarter ended June 2025 as against Rs 14.36 crore during the previous quarter ended June 2024. Sales rose 3.61% to Rs 1542.63 crore in the quarter ended June 2025 as against Rs 1488.83 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1542.631488.83 4 OPM %8.476.30 - PBDT118.3877.82 52 PBT52.7717.79 197 NP42.3614.36 195 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Medplus Health Services schedules board meeting
Medplus Health Services will hold a meeting of the Board of Directors of the Company on 2 August 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Spotlight
Medplus Health hits 52-week high after Q4 PAT rises 54% YoY to Rs 52 cr
Profit before tax (PBT) jumped 91.1% YoY to Rs 61.12 crore in the quarter ended 31st March 2025. Operating EBITDA stood at Rs 80.33 crore, registering the growth of 38.2% compared with Rs 58.13 crore posted in same quarter last year. Operating EBITDA margin improved to 5.3% in Q4 FY25 as against 3.9% in Q4 FY24. In Q4 FY25, the company added 100 stores. As on 31st March 2025, the total store count stood at 4,712. On full year basis, the company's consolidated net profit surged 129.6% to Rs 150.32 crore on 9.1% increase in revenue from operations to Rs 6,136.05 crore in FY25 over FY24. Meanwhile, the company's board approved the appointment of Subrahmanyam Sharma Tatapudi, as chief technology officer (CTO), (earlier serving as deputy chief technology officer), with effect from 27 May 2025. MedPlus Health Services (MedPlus) is an organized pharmacy retail company with both an online and offline presence. The company operates in retail and wholesale sales, import, distribution, manufacturing and contract manufacturing of private-label pharmaceuticals, wellness and FMCG products and full-fledged diagnostic centers. The counter hits 52-week high at Rs 1,052.05 in intraday today.Powered by Capital Market - Live
5 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 16.46%, vs industry avg of 29.09%
Over the last 5 years, market share decreased from 14.8% to 8.16%